# NELARABINE
> **ANDA216038** · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-01-10
## Drug
- **FDA Application Number:** ANDA216038
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NELARABINE
- **Generic name:** NELARABINE
- **Active ingredients:** NELARABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MEITHEAL
- **Manufacturer:** Meitheal Pharmaceuticals Inc
- **First approval:** 2023-01-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216038)
---
*AI Analytics · CC0 1.0*